Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 151-158

  Rice, Louis B ^a   Carias, Lenore L ^b   Bonomo, Robert A ^b   Shlaes, David M ^b  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN; SULBACTAM; SULFAFURAZOLE; TAZOBACTAM; TETRACYCLINE; TRIMETHOPRIM;

ABDOMINAL ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MIXTURE; ESCHERICHIA COLI; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ABDOMINAL ABSCESS; AMINO ACID SEQUENCE; AMPICILLIN; ANIMALS; BASE SEQUENCE; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DNA, BACTERIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR BIOLOGY; MOLECULAR SEQUENCE DATA; PENICILLANIC ACID; PENICILLIN RESISTANCE; PIPERACILLIN; R FACTORS; RATS; SULBACTAM;

EID: 0030063165     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.151     Document Type: Article

References (16)

1. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
2. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990; 34:2193-9.
3. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991-6.
4. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353-8.
5. Rasmussen BA, Bradford PA, Quinn JP, Wiener J, Weinstein RA, Bush K. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of a TEM-10 β-lactamase encoded by different nucleotide sequences. Antimicrob Agents Chemother 1993;37:1989-92.
6. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990;34:2200-9.
7. BIL-I, a plasmid-mediated class C β-lactamase gene in Escherichia coli BS. Antimicrob Agents Chemother 1994;38:1182-5.
8. Rice LB, Carias LL, Shlaes DM. In vivo efficacies of β-lactam-β-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 1994;38: 2663-4.
9. Imtiaz U, Manavathu EK, Mobashery S, Leraer SA. Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 β-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime. Antimicrob Agents Chemother 1994;38:1134-9.
10. Blazquez J, Baquero MR, Canton R, Alos I, Baquero F. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993;37:2059-63.
11. Zhou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob Agents Chemother 1994;38:1085-9.
12. Martinez JL, Cercenado E, Rodriguez-Creixems M, Vincente-Perez MF, Delgado-Iribarren A, Baquero F. Resistance to beta-lactam/clavulanate. Lancet 1987;2:1473.
13. Sanders CC, Iaconis JP, Bodey GP, Samonis G. Resistance to ticarcillinpotassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988;32:1365-9.
14. Williams H, King A, Shannon K, Phillips I. Amoxycillin/clavulanate resistant Escherichia coli. Lancet 1988;1:304-5.
15. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990;34:858-62.
16. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.